drugset / Trial / NCT04756986

Malic Acid in Treatment of Xerostomia

NCT04756986 ↗

Unknown 52 enrolled Hams Hamed Abdelrahman
RandomizedParallel-groupOpen-labelTreatment

Summary

Background: xerostomia is a subjective sensation of dry mouth resulting from quantitative and /or qualitative changes of saliva. Patients receiving drugs like antihypertensives and antidepressants or patients receiving chemotherapy or radiotherapy for treatment of head and neck cancers may suffer from xerostomia. It also can be experienced in patients with systemic diseases like diabetes mellitus, systemic lupus erythematosus, sjogren's syndrome and rheumatoid arthritis. Malic acid spray with concentration of 1% has grabbed the attention over the last few years as an effective treatment for xerostomia. Study objective: To evaluate the effect of 1% malic acid spray in treatment of xerostomia in type 2 diabetic patients.

Timeline

Start
2021-01-01
Primary completion
2021-09-01
Completion
2021-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Malic Acid Small molecule 1 % Topical

Indications

No indication recorded.